Physician

Milind Madhav Karve, MD

According to 2025 Medicare claims, Milind Karve, MD (NPI: 1285609537) practices interventional cardiology in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is CAPITAL CARDIOLOGY PC (NPI: 1710183660; TIN: 208447124) and primary practice location at 48912-1800. Karve is affiliated with the POM ACO (ACO ID: A1297), West Michigan Accountable Care Organization, LLC (ACO ID: A4626), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Karve's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 513 traditional Medicare patients, billed 4,873 HCPCS/CPT codes, and received $267,120 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,372 prescription claims across 807 beneficiaries totaling $776,580 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 22 claims. Open Payments data shows 116 records totaling $3,933. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $496,640 to $267,120. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $708,547 and ending at $776,580. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $26,802 to $2,261.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,143	6,108	$496,640
2016	1,216	5,886	$436,241
2017	1,177	6,352	$480,326
2018	1,117	5,773	$430,467
2019	1,252	6,368	$518,090
2020	707	5,349	$375,408
2021	544	6,472	$368,811
2022	492	5,652	$282,752
2023	535	4,658	$270,261
2024	513	4,873	$267,120

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	908	7,260	$708,547
2016	839	6,644	$752,829
2017	817	5,609	$681,306
2018	763	5,133	$691,925
2019	952	6,664	$910,929
2020	946	7,007	$1,109,321
2021	842	4,912	$929,482
2022	548	2,367	$447,612
2023	512	2,023	$396,661
2024	807	3,372	$776,580

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	110	$9,044
2016	N/R	120	$6,069
2017	N/R	47	$2,166
2018	N/R	17	$930
2019	N/R	14	$797
2020	N/R	22	$1,671
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	319	559	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	100	108	$65
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	119	927	$46
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	120	366	$34
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	243	314	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	229	15,308	$286,703
Xarelto	Rivaroxaban	84	5,924	$104,664
Entresto	Sacubitril/Valsartan	64	3,890	$81,431
Farxiga	Dapagliflozin Propanediol	51	3,068	$56,776
Jardiance	Empagliflozin	38	2,820	$51,991

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$3,933	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Milind Madhav Karve, MD?

Tedicare shows public-source Medicare data for Milind Madhav Karve, MD (NPI 1285609537), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Milind Madhav Karve, MD have ACO affiliation data?

Milind Madhav Karve, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Milind Madhav Karve, MD?

Milind Madhav Karve, MD is linked to CAPITAL CARDIOLOGY PC (billing NPI 1710183660) in the available physician profile data.

Does Milind Madhav Karve, MD have Open Payments data?

Milind Madhav Karve, MD has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.